Keyphrases
United States
100%
Advanced Hepatocellular Carcinoma
100%
Sorafenib
100%
Oncology Practice
100%
Risk of Death
30%
Low Risk
20%
Patient Characteristics
20%
Non-Hispanic White
20%
Child-Pugh Score
20%
High Risk
10%
Radiation Therapy
10%
Clinical Practice
10%
National Cancer Institute
10%
Race-ethnicity
10%
Treatment Outcome
10%
Clinical Characteristics
10%
Systemic Chemotherapy
10%
Treatment Patterns
10%
Sorafenib Treatment
10%
Clinical Factors
10%
Logistic Regression Analysis
10%
Treatment Evaluation
10%
Chemotherapy-only
10%
Patterns of Care Study
10%
Approved Drugs
10%
Trends in Use
10%
Population-based Evaluation
10%
Barcelona Clinic Liver Cancer
10%
First-line Systemic Treatment
10%
Multivariate Cox Proportional Hazard Regression
10%
Medicine and Dentistry
Oncology
100%
Sorafenib
100%
Hepatocellular Carcinoma
100%
Child-Pugh Score
18%
Malignant Neoplasm
9%
Transplantation
9%
Radiation Therapy
9%
Systemic Therapy
9%
Proportional Hazards Model
9%
Multivariate Logistic Regression Analysis
9%
Cancer Staging
9%
Liver Cancer
9%
Nursing and Health Professions
Liver Cell Carcinoma
100%
Sorafenib
100%
Food and Drug Administration
18%
Child Pugh Score
18%
Hospital
9%
Radiotherapy
9%
Clinical Practice
9%
National Health Organization
9%
Transplantation
9%
Systemic Therapy
9%
Proportional Hazards Model
9%
Multivariate Logistic Regression Analysis
9%
Liver Cancer
9%
Cancer Staging
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Sorafenib
100%
Chemotherapy
9%
Systemic Treatment
9%
Malignant Neoplasm
9%
Liver Cancer
9%
Cancer Staging
9%